Cristina Wilbur - Roche Holding Chief Officer

All Insiders . Germany . 
Stock . Roche Holding Ltd . Stakeholders . Insider . Cristina Wilbur
RHO6 Stock  EUR 33.49  0.56  1.64%   

Insider

Cristina Wilbur is Chief Officer of Roche Holding Ltd
Age 56
Phone41 61 688 11 11
Webhttps://www.roche.com

Roche Holding Management Efficiency

The company has return on total asset (ROA) of 0.1468 % which means that it generated a profit of $0.1468 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4483 %, meaning that it generated $0.4483 on every $100 dollars invested by stockholders. Roche Holding's management efficiency ratios could be used to measure how well Roche Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Roche Holding Ltd has accumulated 16.08 B in total debt with debt to equity ratio (D/E) of 0.39, which is about average as compared to similar companies. Roche Holding has a current ratio of 1.27, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Roche Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Roche Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Roche Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Roche to invest in growth at high rates of return. When we think about Roche Holding's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Tao LangSingapore Telecommunications Li
51
Walter UlloaEntravision Communications
74
Jose VillafaneEntravision Communications
N/A
Robert UdellConsolidated Communications Hol
57
Juan WuthenauEntravision Communications
57
Gabe WaggonerConsolidated Communications Hol
N/A
Aileen TanSingapore Telecommunications Li
56
Garrett OsdellConsolidated Communications Hol
N/A
York ChangSingapore Telecommunications Li
56
Lian PekSingapore Telecommunications Li
N/A
Karl MeyerEntravision Communications
59
Siew WooSingapore Telecommunications Li
59
Mark ChongSingapore Telecommunications Li
60
David HerrickConsolidated Communications Hol
N/A
Fred IIIConsolidated Communications Hol
57
Kuan YuenSingapore Telecommunications Li
56
Mark BoelkeEntravision Communications
N/A
Margarita WilderEntravision Communications
N/A
Yang SinSingapore Telecommunications Li
N/A
Tom WhiteConsolidated Communications Hol
N/A
Edward MelendezEntravision Communications
N/A
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE HLDG operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 101465 people. Roche Holding Ltd (RHO6) is traded on Frankfurt Exchange in Germany and employs 103,613 people.

Management Performance

Return On Equity0.45
Return On Asset0.15

Roche Holding Leadership Team

Elected by the shareholders, the Roche Holding's board of directors comprises two types of representatives: Roche Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Roche. The board's role is to monitor Roche Holding's management team and ensure that shareholders' interests are well served. Roche Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Roche Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
Claudia Bockstiegel, G Counsel
Barbara Schadler, Head Communications
Johannes MD, Head Devel
Bruno Eschli, Head Relations
Thomas Schinecker, Chief Diagnostics
Cristina Wilbur, Chief Officer
William Anderson, Chief Pharmaceuticals
Alan Hippe, Chief Officer
Severin Schwan, CEO Director
Pascale Schmidt, Chief Officer

Roche Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Roche Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.45
Return On Asset0.15
Profit Margin0.19 %
Operating Margin0.32 %
Current Valuation273.87 B
Shares Outstanding6.39 B
Shares Owned By Institutions1.28 %
Price To Earning21.74 X
Price To Book9.68 X
Price To Sales3.82 X

Currently Active Assets on Macroaxis

ESRTEmpire State Realty
CCitigroup
CCitigroup
GOOGAlphabet Inc Class C
DDDupont De Nemours

Other Information on Investing in Roche Stock

Roche Holding financial ratios help investors to determine whether Roche Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Roche with respect to the benefits of owning Roche Holding security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY